Overview

In India, lung cancer accounts for around 5.9% of all new cancer cases and 8.1% of all cancer deaths, making it one of the leading causes of cancer mortality. Most cases are diagnosed at an advanced stage due to the absence of early symptoms.

Low-dose computed tomography (LDCT) screening has been found to help reduce lung cancer deaths, especially in high-risk populations. Wide-spread screening programs in India could lead to earlier diagnoses and better chances of survival

How It Works:

Low-dose computed tomography (LDCT) uses advanced X-ray technology to produce detailed cross-sectional images of the lungs with a reduced radiation dose compared to a standard CT scan. This allows for safer, more frequent annual screenings. LDCT can help detect small nodules or abnormalities in the lungs early, enabling healthcare providers to determine if further investigation or treatment is necessary.

Low-dose computed tomography (LDCT) can detect lung cancer at an earlier stage when it is still localized. Early detection increases the likelihood of successful treatment and significantly improves survival rates.

LDCT uses a lower dose of radiation than standard CT scans, making it safer for repeated annual screenings. This is particularly important for high-risk individuals who need frequent monitoring.

By diagnosing lung cancer early, patients have more treatment options that are less invasive, leading to improved outcomes and better quality of life.

Detecting lung cancer at an early stage can lead to reduced treatment costs compared to the expenses incurred when treating advanced-stage cancer, which often requires more complex and costly interventions.

Regular screenings allow healthcare providers to monitor changes in lung nodules or abnormalities over time. This vigilance enables timely interventions if new or growing nodules are detected.